- Products & Services
- Knowledge Base
SAN FRANCISCO, CA, May 05, 2023 /24-7PressRelease/ -- The 3rd Annual Psychedelic Therapeutics & Drug Development Conference, a global gathering of leading researchers, scientists, and healthcare professionals, is set to take place on May 15-16, 2023 at the Hilton SFO Bayfront in Burlingame, CA. The conference will provide a unique platform for participants to present and discuss the latest research findings and future directions in the rapidly evolving field of psychedelic research.
The conference will feature presentations from leading experts in the field, including researchers, healthcare professionals, and policy makers. The presentations will cover a wide range of topics, from the latest clinical trials investigating the therapeutic potential of psychedelics in the treatment of mental health disorders such as depression, anxiety, PTSD, addiction, and end-of-life distress, to the neurobiological mechanisms of action of psychedelics and the potential implications for the future of neuroscience.
In addition to the presentations, the conference will include interactive workshops, poster sessions, and networking opportunities, providing participants with the chance to connect with other professionals and collaborate on new research projects.
Featured Speakers Include:
Boris Heifets, Assistant Professor of Anesthesiology, Perioperative & Pain Medicine, Stanford University
Tim Schlidt, Co-founder & Partner, Palo Santo
Hailey Gilmore, Medical Affairs Program Manager, MAPS Public Benefit Corporation
Gul Dolen, Associate Professor of Neuroscience, Brain Institute, Wendy Klag Center, Johns Hopkins University
Matias Serebrinsky, Co-founder, PsyMed Ventures
James Kuo, Vice President of R&D, Silo Pharma
Sabrina Ramkellawan, Chief Operations Officer & Co-Founder, Knowde Group
"We are thrilled to be hosting the Psychedelics Research Conference," said John Waslif, the conference organizer. "This is a unique opportunity for researchers and healthcare professionals from around the world to come together and share their latest findings and insights into the rapidly evolving field of psychedelic research. We believe that this conference will be an important step forward in advancing our understanding of the therapeutic potential of psychedelics and the role they can play in improving mental health and wellbeing."
The conference is open to anyone with an interest in the field of psychedelic research, including researchers, healthcare professionals, policy makers, students, and members of the public. Registration is now open.
For more information about the conference and to register, please visit www.psychedelics-conference.com.
Arrowhead Conferences offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward.
# # #